Question 1251 — diseases

Summary

Mrs Béatrice Roullaud alerts the Minister of Health and Access to Care about pediatric cancers. In France, 1 in 440 children develop cancer before the age of 15. Every year, nearly 500 children and adolescents die from it and more than 2,500 new cases are diagnosed. The number of childhood cancers has increased by 1 to 2% per year in Europe for 30 years. While cancer is the leading cause of death from childhood illness, It appears that life expectancy linked to certain pediatric cancers is not changing favorably due to the lack of financial resources allocated to research in France. Since 2018, research into specific childhood cancer has benefited from a fund of 5 million per year, or only 3% of public funding for cancer research, a rate that is far insufficient to support both research work fundamental in laboratories in order to better understand the causes of cancer developments in children, but also clinical research - respecting animal welfare as much as possible - with new innovative treatments. During the discussion of the finance law for 2022, the deputies had certainly allowed this fund to be increased by 20 million euros but the State must be able to guarantee recurring dedicated credits to confirmed research teams. The law aimed at strengthening the treatment of pediatric cancers of March 8, 2019 establishes the leading role of the National Cancer Institute, responsible for proposing and implementing a ten-year strategy to fight cancer and develop research. She therefore asks him to please specify what share of public funds this strategy defined by decree no. 2021-119 of February 4 2021 plans to allocate to pediatric cancer research, in order to be able to assess whether the Government is finally taking stock of this issue.

Machine translation from French. The official text remains authoritative.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.